急性肺栓塞危险因素的研究进展
Research Progress on Risk Factors for Acute Pulmonary Embolism
摘要: 急性肺栓塞是来自静脉系统或右心的血栓阻塞肺动脉或其分支所导致的以肺循环和呼吸功能障碍为主要临床表现的病理生理特征的疾病。急性肺栓塞是世界范围内一个重要的死亡原因，因为大多数急性肺栓塞死亡发生在最初的几个小时到几天内，所以早期诊断和干预至关重要。本研究探讨了急性肺栓塞的危险因素研究进展。寻找其危险因素是减少急性肺栓塞发病率和减轻急性肺栓塞病情严重程度的主要方法。
Abstract: Acute pulmonary embolism is a disease with pulmonary circulation and respiratory dysfunction as the main clinical manifestations caused by a thrombus obstruction of the pulmonary artery or its branches from the venous system or right heart. Acute PE is an important cause of death worldwide, and early diagnosis and intervention are critical, as most acute PE deaths occur within the first few hours to days. This study explores the progress of risk factors for acute pulmonary embolism. Find-ing risk factors is the mainstay of reducing the incidence and severity of acute PE.
文章引用：张紫依, 李玉红. 急性肺栓塞危险因素的研究进展[J]. 临床医学进展, 2023, 13(5): 8512-8518. https://doi.org/10.12677/ACM.2023.1351192

参考文献

[1] LeVarge, B., Wright, C. and Rodriguez-Lopez, J. (2018) Surgical Management of Acute and Chronic Pulmonary Embo-lism. Clinics in Chest Medicine, 39, 659-667. [Google Scholar] [CrossRef] [PubMed]
[2] Yavuz, S., Toktas, F., Goncu, T., et al. (2014) Surgical Embolectomy for Acute Massive Pulmonary Embolism. International journal of clinical and experimental medicine, 7, 5362-5375.
[3] Jadaon, M.M. (2011) Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region. Mediterranean Journal of Hematology and Infectious Diseases, 3, e2011054. [Google Scholar] [CrossRef] [PubMed]
[4] Key, N.S. et al. (2020) Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: ASCO Clinical Practice Guideline Update. Journal of Clinical Oncology, 38, 496-520. [Google Scholar] [CrossRef] 
[5] RIETE Registry (2022) Death within 30 Days. RIETE Registry.
https://rieteregistry.com/graphics-interactives/dead-30-days/
[6] Yuan, S., et al. (2021) Overall and Abdominal Obesity in Relation to Venous Thromboembolism. Journal of Thrombosis and Haemostasis, 19, 460-469. [Google Scholar] [CrossRef] [PubMed]
[7] Lutsey, P.L. et al. (2020) Long-Term Association of Venous Thromboem-bolism with Frailty, Physical Functioning and Quality of Life: The Atherosclerosis Risk in Communities Study. Journal of the American Heart Association, 9, e015656. [Google Scholar] [CrossRef] 
[8] Reda, S., Rühl, H., Witkowski, J., Müller, J., Pavlova, A., Oldenburg, J. and Pötzsch, B. (2021) PC Deficiency Testing: Throm-bin-Thrombomodulin as PC Activator and Aptamer-Based Enzyme Capturing Increase Diagnostic Accuracy. Frontiers in Cardiovascular Medicine, 8, Article 755281. [Google Scholar] [CrossRef] [PubMed]
[9] Cooper, P.C., Hill, M. and Maclean, R.M. (2012) The Phenotypic and Genetic Assessment of Protein C Deficiency. International Journal of Laboratory Hematology, 34, 336-346. [Google Scholar] [CrossRef] 
[10] Hong, J., Ahn, S.Y., Lee, Y.J., et al. (2021) Updated Recommendations for the Treatment of Venous Thromboembolism. Blood Re-search, 56, 6-16. [Google Scholar] [CrossRef] [PubMed]
[11] Kujovich, J.L. (2018) Factor V Leiden Thrombo-philia. In: Adam, M.P., et al., Eds., GeneReviews, University of Washington, Seattle.
[12] Simone, B., et al. (2013) Risk of Venous Thromboembolism Associated with Single and Combined Effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate Reductase C677T: A Metaanalysis Involving over 11,000 Cases and 21,000 Controls. European Journal of Epidemiology, 28, 621-647. [Google Scholar] [CrossRef] [PubMed]
[13] Chaturvedi, S., et al. (2020) Complement Activity and Comple-ment Regulatory Gene Mutations Are Associated with Thrombosis in APS and CAPS. Blood, 135, 239-251. [Google Scholar] [CrossRef] [PubMed]
[14] Fanola, C.L., et al. (2020) Incident Heart Failure and Long-Term Risk for Venous Thromboembolism. Journal of the American College of Cardiology, 75, 148-158. [Google Scholar] [CrossRef] [PubMed]
[15] Calkovska, A., Mokra, D. and Calkovsky, V. (2009) Lung Surfac-tant Alterations In pulmonary Thromboembolism. European Journal of Medical Research, 14, 38-41. [Google Scholar] [CrossRef] 
[16] Lutsey, P.L., et al. (2022) Incidence and Risk Factors of Pul-monary Hypertension after Venous Thromboembolism: An Analysis of a Large Health Care Database. Journal of the American Heart Association, 11, e024358. [Google Scholar] [CrossRef] 
[17] Gangireddy, C., et al. (2007) Risk Factors and Clinical Impact of Postoperative Symptomatic Venous Thromboembolism. Journal of Vascular Surgery, 45, 335-341. [Google Scholar] [CrossRef] [PubMed]
[18] Moubayed, S.P., Eskander, A., Mourad, M.W. and Most, S.P. (2017) Systematic Review and Meta-Analysis of Venous Thromboembolism in Otolaryngology-Head and Neck Surgery. Head & Neck, 39, 1249-1258. [Google Scholar] [CrossRef] [PubMed]
[19] 闫莉丽, 张春梅, 杨涛. 妊娠晚期静脉血栓栓塞症发生的危险因素分析及其改善措施研究[J]. 中国计划生育和妇产科, 2019, 11(10): 92-96.
[20] 韩肖燕, 杨吉刚, 杨桦. 肺灌注显像技术在孕产妇肺栓塞诊断中的应用[J]. 临床和实验医学杂志, 2019, 18(7): 772-776.
[21] 苏敏, 杨娟娟, 张玉泉. 羊水栓塞与产科血栓栓塞性肺栓塞诊治的异同点[J]. 中国实用妇科与产科杂志, 2018, 34(7): 721-725.
[22] Fer-rari, F., Martins, V.M., Teixeira, M., Santos, R.D. and Stein R. (2021) COVID-19 and Thromboinflammation: Is There a Role for Statins? Clinics, 76, e2518. [Google Scholar] [CrossRef] [PubMed]
[23] Zuo, Y., Zuo, M., Yalavarthi, S., Gockman, K., Madison, J.A., Shi, H., Woodard, W., Lezak, S.P., Lugogo, N.L., Knight, J.S. and Kanthi, Y. (2021) Neutrophil Extracellular Traps and Thrombosis in COVID-19. Journal of Thrombosis and Thrombolysis, 51, 446-453. [Google Scholar] [CrossRef] [PubMed]
[24] Caruso, D., Zerunian, M., Polici, M., Pucciarelli, F., Polidori, T., Rucci, C., Guido, G., Bracci, B., de Dominicis, C. and Laghi, A. (2020) Chest CT Features of COVID-19 in Rome, Italy. Radiology, 296, E79-E85.
[25] Canonico, M.E., Siciliano, R., Scudiero, F., Sanna, G.D. and Parodi, G. (2020) The Tug-of-War between Coagulopathy and Anticoagulant Agents in Patients with COVID-19. European Heart Jour-nal-Cardiovascular Pharmacotherapy, 6, 262-264. [Google Scholar] [CrossRef] [PubMed]
[26] Paranjpe, I., Fus-ter, V., Lala, V., Russak, A., Glicksberg, B.S., Levin, M.A., Charney, A.W., Narula, J., Fayad, Z.A., Bagiella, E., Zhao, S. and Nadkarni, G.N. (2020) Association of Treatment Dose Anticoagulation with In-Hospital Survival among Hospi-talized Patients with COVID-19. Journal of the American College of Cardiology, 76, 122-124. [Google Scholar] [CrossRef] [PubMed]
[27] Scudiero, F., Silverio, A., Di Maio, A., Russo, V., Citro, R., Per-soneni, D., et al. (2021) Pulmonary Embolism in COVID-19 Patients: Prevalence, Predictors and Clinical Outcome. Thrombosis Research, 198, 34-39. [Google Scholar] [CrossRef] [PubMed]
[28] Lidegaard, O., Nielsen, L.H., Skovlund, C.W., Skjeldestad, F.E. and Lokkegaard, E. (2021) Risk of Venous Thromboembolism from Use of Oral Contraceptives Containing Differ-ent Progestogens and Oestrogen Doses: Danish Cohort Study, 2001-9. BMJ, 343, d6423. [Google Scholar] [CrossRef] [PubMed]
[29] Li, J., et al. (2018) Association of Risk for Venous Thromboembolism with Use of Low-Dose Extended and Continuous-Cycle Combined Oral Contraceptives: A Safety Study Using the Sentinel Distributed Database. JAMA Internal Medicine, 178, 1482-1488. [Google Scholar] [CrossRef] [PubMed]
[30] Sultan, A.A., Tata, L.J., West, J., et al. (2013) Risk Factors for First Venous Thromboembolism around Pregnancy: A Population-Based Cohort Study from the United Kingdom. Blood, 121, 3953-3961. [Google Scholar] [CrossRef] [PubMed]
[31] Jacobsen, A.F., Skjeldestad, F.E. and Sandset, P.M. (2008) Ante- and Postnatal Risk Factors of Venous Thrombosis: A Hospital-Based Case—Control Study. Journal of Throm-bosis and Haemostasis, 6, 905-912. [Google Scholar] [CrossRef] [PubMed]
[32] Horsted, F., West, J. and Grainge, M.J. (2012) Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis. PLOS Medicine, 9, e1001275. [Google Scholar] [CrossRef] [PubMed]
[33] Hoisnard, L., et al. (2022) Adverse Events Associ-ated With JAK Inhibitors in 126,815 Reports from the WHO Pharmacovigilance Database. Scientific Reports, 12, Article No. 7140. [Google Scholar] [CrossRef] [PubMed]
[34] Razak, N.B.A., Jones, G., Bhandari, M., Berndt, M.C. and Metharom, P. (2018) Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treat-ment. Cancers, 10, 380. [Google Scholar] [CrossRef] [PubMed]
[35] Mahmoodi, B.K., et al. (2017) Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Me-ta-Analysis of Prospective Studies. Circulation, 135, 7-16. [Google Scholar] [CrossRef] 
[36] Folsom, A.R., de Vries, P.S. and Cushman, M. (2021) No Prospective Association of a Polygenic Risk Score for Coronary artery DISEASE with Venous Thromboem-bolism Incidence. Journal of Thrombosis and Haemostasis, 19, 2841-2844. [Google Scholar] [CrossRef] [PubMed]
[37] Elisia, I., et al. (2020) The Effect of Smoking on Chronic Inflammation, Immune Function and Blood Cell Composition. Scientific Reports, 10, Article No. 19480. [Google Scholar] [CrossRef] [PubMed]

为你推荐